LINC00900

Across TCGA pan-cancer cohorts, LINC00900 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of LINC00900’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC00900 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00900 is over-expressed in tumor, although a few such as HNSC and UCEC show the opposite, repressed pattern.

KIRC, HNSC, and KIRP are the cancer types where LINC00900 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00900 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.913	<.001	12	view →
HNSC	Male	IV	−0.914	<.001	10	view →
KIRP	Male	All	+0.807	<.001	8	view →
THCA	Female	III,IV	+1.128	<.001	7	view →
UCEC	All	II,III,IV	−1.053	<.001	6	view →
LUAD	All	All	+0.444	<.001	5	view →
COAD	All	All	−0.166	.003	4	view →
KICH	Male	II,III,IV	−0.195	.009	3	view →
LIHC	All	All	+0.095	.020	3	view →
PRAD	All	All	−0.538	<.001	2	view →
LUAD	All	IV	−0.400	.006	2	view →
CHOL	All	All	+0.342	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

LINC00900–KIRC

Open the KIRC breakdown →